Results 11 to 20 of about 2,652 (202)
Brincidofovir (BCV) and tecovirimat are the only two chemical drugs that have been approved to treat smallpox and can be requested for monkeypox (Mpox) treatment through a single-patient Emergency Investigational New Drug (EIND) application ...
Yanmin Wan, Zhaoqin Zhu, Chao Qiu
exaly +4 more sources
The Role of Brincidofovir in Preparation for a Potential Smallpox Outbreak [PDF]
Smallpox (variola) virus is considered a Category A bioterrorism agent due to its ability to spread rapidly and the high morbidity and mortality rates associated with infection. Current recommendations recognize the importance of oral antivirals and call
Scott A. Foster +2 more
doaj +3 more sources
Brincidofovir inhibits polyomavirus infection in vivo
Polyomaviruses are species-specific DNA viruses that can cause disease in immunocompromised individuals. Despite their role as the causative agents for several diseases, there are no currently approved antivirals for treating polyomavirus infection ...
Arrienne B. Butic +6 more
doaj +3 more sources
Mpox (Monkeypox): A Comprehensive Review of Etiology, Epidemiology, Transmission, Clinical Presentation, Diagnosis, Treatment, and Prevention [PDF]
Introduction: The objective of this review is to provide a comprehensive overview of the current state of knowledge about mpox (monkeypox), its etiology, epidemiology, transmission, clinical features, diagnosis, treatment, and prevention.
Urszula Mazur +9 more
doaj +3 more sources
Pseudorabies is an acute and febrile infectious disease caused by pseudorabies virus (PRV), a member of the family Herpesviridae. Currently, PRV is predominantly endemoepidemic and has caused significant economic losses among domestic pigs. Other animals
Huihui Guo +7 more
doaj +3 more sources
Disseminated Mpox infection, a rare case of an immunocompromised patient treated with tecovirimat and brincidofovir [PDF]
Paytra A. Klein, MBA +2 more
doaj +2 more sources
Mpox in South Asia: A Narrative Review on Epidemiology, Preparedness, and Preventive Strategies. [PDF]
ABSTRACT Background and Aims Monkeypox (Mpox), due to its growing global concern, was declared a public health emergency of worldwide concern by the World Health Organization in August 2024. The monkeypox virus (MPXV), once limited to African regions, has now spread to South Asia, including Pakistan, India, Nepal, and Sri Lanka, and there have been ...
Mawa J +5 more
europepmc +2 more sources
Battle won, war ongoing: A call for mpox vaccination in high-risk dermatologic cases [PDF]
Atika Malik, MD +4 more
doaj +2 more sources
African swine fever virus (ASFV) infection is a major public and socioeconomic concern that has a serious impact on the global swine industry. Unfortunately, there are currently no commercially available vaccines or antiviral agents that are both safe ...
Shibang Guo +12 more
doaj +1 more source
Antivirals against Monkeypox (Mpox) in Humans: An Updated Narrative Review
As of 29 August 2023, a total of 89,596 confirmed cases of Mpox (monkeypox) have been documented across 114 countries worldwide, with 157 reported fatalities.
Giuseppe Bruno +1 more
doaj +1 more source

